Table 1.
Study measures and outcomes.
Description | Measure | Ref. |
---|---|---|
Sociodemographic /medical information | Self-report and medical record | NA |
Tobacco use and knowledge | CDC-QIT | 15 |
Other substance use | NIH/NIAID Baseline Substance Use Report | 18 |
Nicotine addiction | Modified Fagerstrom Tolerance Questionnaire | 19 |
Motivation to quit | Modified Abrams & Biener Readiness to Quit Ladder | 20 |
Self-efficacy | Self-efficacy/Temptations Scale | 21 |
Decisional balance | Smoking Decisional Balance Short Form | 22 |
Social support | Interpersonal Support Evaluation List | 23 |
Loneliness | UCLA Loneliness Scale | 24 |
Depression | Center for Epidemiologic Studies Depression Scale | 25 |
Anxiety | General Anxiety Disorder-7 | 26 |
Perceived stress | Perceived Stress Scale – 4 Item | 27 |
Study Outcomes | ||
Adherence | # of sessions logged into; #web pages visited | NA |
Engagement | # of interactive clicks; # total minutes logged in; | NA |
Satisfaction* | Satisfaction survey designed by study team | NA |
Study contamination** | Questionnaire designed by study team | NA |
Abstinence (by history) | Seven-day point-prevalence abstinence at 3 months | 28 |
Abstinence (biochemical) | Exhaled carbon monoxide<10 parts per million*** | 29 |
Note: NA=not applicable, CDC-QIT=Centers for Disease Control-Question Inventory on Tobacco, NIH/NIAID=National Institutes of Health/National Institute of Allergy and Infectious Diseases, UCLA=University of California, Los Angeles
PSFW subjects only
Standard care subjects only
Measured using the Bedfont piCO+ Smokerlyzer (Bedfont Scientific Ltd., Kent, UK) according to manufacturer’s instructions.